Introduction
This quiz collection on Analog Design: Classical and Non-classical Bioisosteres is tailored for M.Pharm students preparing for advanced medicinal chemistry exams. It consolidates core concepts—definitions, classical versus non-classical distinctions, common replacement strategies, and practical consequences on potency, ADME and toxicity—into focused multiple-choice questions. Each item probes mechanistic reasoning and real-world scaffold replacements used in drug design, such as carboxylate-to-tetrazole or CH→N exchanges, and highlights how isosteric swaps affect pKa, lipophilicity, hydrogen bonding and metabolic stability. Use these MCQs to test understanding, refine replacement choices and improve skills in rational analog design and scaffold hopping.
Q1. What is the most accurate definition of a bioisostere in medicinal chemistry?
- Chemical substituents or groups with similar physical or chemical properties that produce broadly similar biological effects.
- Any functional group that increases molecular weight and lipophilicity.
- A pharmacophore element that always increases potency when substituted.
- A structural modification that only changes the stereochemistry of a molecule.
Correct Answer: Chemical substituents or groups with similar physical or chemical properties that produce broadly similar biological effects.
Q2. Which statement best distinguishes classical from non-classical bioisosteres?
- Classical are based on same valence electron count and size; non-classical are replacements with different electronic structure but similar biological activity.
- Classical are always heterocycles; non-classical are always alkyl groups.
- Classical bioisosteres change stereochemistry; non-classical preserve stereochemistry.
- There is no difference; the terms are interchangeable.
Correct Answer: Classical are based on same valence electron count and size; non-classical are replacements with different electronic structure but similar biological activity.
Q3. Which of the following is a classical bioisosteric pair frequently exploited in drug design?
- Oxygen (O) and sulfur (S)
- Carboxylic acid and tetrazole
- Benzene and pyridine
- Amide and 1,2,4-oxadiazole
Correct Answer: Oxygen (O) and sulfur (S)
Q4. Which is a prototypical example of a non-classical bioisosteric replacement used to mimic carboxylic acids?
- Carboxylic acid ↔ Tetrazole (pKa mimicry, lipophilicity change)
- Carboxylic acid ↔ Methyl
- Carboxylic acid ↔ Nitro group
- Carboxylic acid ↔ Aldehyde
Correct Answer: Carboxylic acid ↔ Tetrazole (pKa mimicry, lipophilicity change)
Q5. Which bioisosteric change is commonly used to increase metabolic stability by removing an ester hydrolysis liability?
- Ester → Amide
- Ester → Alcohol
- Ester → Aldehyde
- Ester → Nitro group
Correct Answer: Ester → Amide
Q6. Replacing a carboxylate with which group typically preserves anionic character while increasing lipophilicity and membrane permeability?
- Carboxylate → Tetrazole
- Carboxylate → Alcohol
- Carboxylate → Methyl
- Carboxylate → Aldehyde
Correct Answer: Carboxylate → Tetrazole
Q7. What is the primary medicinal-chemistry rationale for substituting hydrogen with fluorine at a metabolically labile site?
- Fluorine substitution can increase metabolic stability by blocking oxidative metabolism and modulate pKa.
- Fluorine always increases molecular weight beyond bioavailability limits.
- Fluorine converts H-bond donors into H-bond donors.
- Fluorine substitution guarantees improved solubility in water.
Correct Answer: Fluorine substitution can increase metabolic stability by blocking oxidative metabolism and modulate pKa.
Q8. What is the primary purpose of matched molecular pair analysis (MMPA) in bioisostere-driven optimization?
- Quantitative evaluation of the effect of small chemical changes on activity and properties.
- To perform three-dimensional docking of large libraries.
- To synthesize compounds in fewer steps.
- To remove all heteroatoms from a series.
Correct Answer: Quantitative evaluation of the effect of small chemical changes on activity and properties.
Q9. To reduce basicity of a tertiary aliphatic amine while retaining a binding interaction, which non-classical replacement is commonly used?
- Replace tertiary alkylamine with a pyridine or imidazole ring
- Replace tertiary alkylamine with a quaternary ammonium
- Replace tertiary alkylamine with an alkyl chloride
- Replace tertiary alkylamine with nitrobenzene
Correct Answer: Replace tertiary alkylamine with a pyridine or imidazole ring
Q10. Which classical isosteric replacement is typically used to probe hydrogen-bond acceptor changes of a carbonyl?
- C=O ↔ C=S (thioamide/thioester)
- C=O ↔ NO2
- C=O ↔ CH2
- C=O ↔ OH
Correct Answer: C=O ↔ C=S (thioamide/thioester)
Q11. Which non-classical aromatic replacement is often applied in scaffold hopping to alter electronics and H-bonding without major steric change?
- Benzene ↔ Heteroaromatics like pyridine or thiophene
- Benzene ↔ Saturated cyclohexane only
- Benzene ↔ Nitrobenzene always
- Benzene ↔ Carboxylic acid
Correct Answer: Benzene ↔ Heteroaromatics like pyridine or thiophene
Q12. What is a major advantage of replacing a carboxylic acid with a tetrazole in an orally active drug?
- Enhanced metabolic stability, increased lipophilicity and similar pKa
- Complete elimination of ionization at physiological pH
- Guaranteed increase in solubility without other changes
- Removal of any potential for hydrogen bonding
Correct Answer: Enhanced metabolic stability, increased lipophilicity and similar pKa
Q13. Which replacement removes a hydrogen-bond donor while keeping steric size similar and is often used to reduce polarity?
- -OH → -F
- -OH → -NH2
- -OH → -COOH
- -OH → -SH
Correct Answer: -OH → -F
Q14. What is the key objective of scaffold hopping in analog design?
- Change the core scaffold to retain activity but improve properties and explore IP space
- Increase molecular weight to over 800 Da
- Convert all polar groups to charged species
- Replace all heteroatoms with carbon only
Correct Answer: Change the core scaffold to retain activity but improve properties and explore IP space
Q15. Which pair exemplifies a classical monovalent bioisosteric replacement commonly used to influence lipophilicity and metabolism?
- H ↔ F
- OH ↔ COOH
- NH2 ↔ CO
- SO2 ↔ CH3
Correct Answer: H ↔ F
Q16. Which non-classical replacement can be used to remove an amide NH hydrogen-bond donor while retaining a similar geometry and electronic distribution?
- Amide → 1,2,4‑oxadiazole
- Amide → Alcohol
- Amide → Nitro group
- Amide → Methylene
Correct Answer: Amide → 1,2,4‑oxadiazole
Q17. Which bioisosteric change is most likely to reduce the basicity (lower the pKa) of a molecule?
- Tertiary amine → Amide reduces basicity and lowers pKa
- Tertiary amine → Quaternary ammonium reduces basicity
- Tertiary amine → Secondary amine always lowers pKa
- Tertiary amine → Ether lowers pKa
Correct Answer: Tertiary amine → Amide reduces basicity and lowers pKa
Q18. To reduce the toxicological risk associated with an aromatic nitro group, which non-classical substitution is often considered?
- Replace aromatic nitro with cyano or trifluoromethyl to reduce toxicity
- Replace nitro with another nitro at a different position only
- Replace nitro with a primary amine to increase nitroreduction
- Leave the nitro intact because it never causes problems
Correct Answer: Replace aromatic nitro with cyano or trifluoromethyl to reduce toxicity
Q19. Which computational tools or resources are specifically developed to suggest bioisosteric replacements?
- BROOD and BIOSTER
- Gaussian and NMRPipe only
- Excel spreadsheets without chemical data
- Generic image editors
Correct Answer: BROOD and BIOSTER
Q20. Replacing a CH group in an aromatic ring with a nitrogen atom (CH → N) most directly affects which properties?
- pKa, hydrogen bonding and polarity (due to introduction of heteroatom)
- Molecular weight only, with no change to electronics
- Only color and UV absorption but not binding
- Eliminates all activity regardless of context
Correct Answer: pKa, hydrogen bonding and polarity (due to introduction of heteroatom)

I am a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. I hold a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research. With a strong academic foundation and practical knowledge, I am committed to providing accurate, easy-to-understand content to support pharmacy students and professionals. My aim is to make complex pharmaceutical concepts accessible and useful for real-world application.
Mail- Sachin@pharmacyfreak.com

